Recent News

• 06.12.2025 - Lifecore Biomedical Receives Accelerated Payment of Remaining $10 Million in Proceeds from Prior Equipment Sale
• 05.27.2025 - Lifecore Biomedical Names Mark DaFonseca Chief Commercial Officer
• 05.01.2025 - Tom Salus
• 04.22.2025 - Lifecore Biomedical to Participate at Upcoming CDMO Live 2025 Conference
• 04.16.2025 - Lifecore Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
• 04.14.2025 - Lifecore Biomedical Appoints Thomas D. Salus as Chief Legal and Administration Officer
• 04.03.2025 - Q3 2025 Lifecore Biomedical Earnings Conference Call
• 04.03.2025 - Lifecore Biomedical Reports Third Quarter Fiscal 2025 Financial Results and Provides Corporate Update

Recent Filings

• 05.29.2025 - SCHEDULE 13D/A General Statement of Acquisition of Beneficial Ownership
• 05.28.2025 - 4 Statement of changes in beneficial ownership of securities
• 05.22.2025 - 4 Statement of changes in beneficial ownership of securities
• 05.16.2025 - 4 Statement of changes in beneficial ownership of securities
• 05.12.2025 - 4 Statement of changes in beneficial ownership of securities
• 05.07.2025 - 4 Statement of changes in beneficial ownership of securities
• 04.16.2025 - 8-K Current report
• 04.16.2025 - 4 Statement of changes in beneficial ownership of securities
• 04.16.2025 - 3 Initial statement of beneficial ownership of securities
• 04.10.2025 - 8-K Current report